| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |